Aptevo Therapeutics Inc. Common Stock (NASDAQ: APVO) last traded at $1.84, up 2.79% on the session. The quote above updates while this page is open; the figures below are drawn from Aptevo Therapeutics Inc. Common Stock’s own filings and are restated only when a new one is published.
Aptevo Therapeutics Inc. Common Stock trades on NASDAQ under the ticker APVO. Its market capitalisation is $3.31 million.
Valuation measures for Aptevo Therapeutics Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $3.31M |
|---|---|
| Enterprise value | $1.99M |
| Price / book | 0.55 |
| Beta | 1.16 |
Trailing-twelve-month figures tagged in Aptevo Therapeutics Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$26.41M |
| Return on equity | -437.15% |
|---|
| Cash | $9.80M |
|---|
Range and volume for APVO over the past 52 weeks.
| 52-week high | $30.06 |
|---|---|
| 52-week low | $1.37 |
| Volume | 240.8K |
| Average volume | 93.2K |
| Previous close | $1.79 |
Invest a chosen dollar amount in Aptevo Therapeutics Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell APVO.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.